Article Details

DiaCarta going public on NYSE through special purpose acquisition company

Retrieved on: 2022-10-14 14:41:45

Tags for this article:

Click the tags to see associated articles and topics

DiaCarta going public on NYSE through special purpose acquisition company. View article details on hiswai:

Excerpt

DiaCarta said that its liquid biopsy diagnostic testing technologies are underpinned by its XNA and SuperbDNA technology platforms.

Article found on: www.labpulse.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up